EGFR and non-small cell lung carcinoma: The common 15 bp or 18 bp deletions in the epidermal growth factor receptor (EGFR) gene, commonly found in 5–20% of patients with non-small cell lung cancers [10], were chosen as models to explore the analytical sensitivity and analytical selectivity of MAP.